Metraipolis › archive › dc_54f3ebfdb86b
High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma — Europe PMC PMID:41467459
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41467459
- DOI
- 10.1111/pin.70076
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T08:01:53.895Z
- SHA-256 of the archived text
405d771d808a5d791d71efd3eb15cea4eee1bf27b19dc300b188fb68c45284df- Stable URL of this page
https://metraipolis.com/documento/dc_54f3ebfdb86b
How to cite
High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma — Europe PMC PMID:41467459 — Europe PMC (en), https://europepmc.org/article/MED/41467459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54f3ebfdb86b (Metraipolis archive dc_54f3ebfdb86b, sha256 405d771d808a5d791d71efd3eb15cea4eee1bf27b19dc300b188fb68c45284df)
BibTeX
@misc{dc54f3ebfdb86b,
title = {High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma — Europe PMC PMID:41467459},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41467459},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54f3ebfdb86b; sha256 405d771d808a5d791d71efd3eb15cea4eee1bf27b19dc300b188fb68c45284df},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41467459. Agents can read the archived copy with the MCP tool read_document.